Team:USTC CHINA/Project/Background
From 2013.igem.org
(Difference between revisions)
Line 74: | Line 74: | ||
<h2>THREE:How Can We Make it?<h2> | <h2>THREE:How Can We Make it?<h2> | ||
<h3>1. Everything was So Naive Before We Found TD1.<h3> | <h3>1. Everything was So Naive Before We Found TD1.<h3> | ||
- | <p>When this idea first stroke us, it seemed amazing that our dream is so naïve and unpractical. Above all, how can we make antigen get through the skin barrier? We refer to various transdermal methods, like Iontophoresis, Sonophoresis, Microneedle. They require special equipment and deal damage to skin. Our idea remained unrealistic until we find Transdermal peptide 1.<p> | + | <p align="justify">When this idea first stroke us, it seemed amazing that our dream is so naïve and unpractical. Above all, how can we make antigen get through the skin barrier? We refer to various transdermal methods, like Iontophoresis, Sonophoresis, Microneedle. They require special equipment and deal damage to skin. Our idea remained unrealistic until we find Transdermal peptide 1.<p> |
<p>TD-1 is an eleven amino acid peptide, which can greatly facilitate macromolecule transdermal delivery through intact skin. This was first discovered by professor Wen Longping in our university and the results were published on Nature biotechnology.<p> | <p>TD-1 is an eleven amino acid peptide, which can greatly facilitate macromolecule transdermal delivery through intact skin. This was first discovered by professor Wen Longping in our university and the results were published on Nature biotechnology.<p> | ||
TD1 Sequence<br> | TD1 Sequence<br> |
Revision as of 19:59, 27 September 2013